Review | Moving forward again, EverBridge's successful participation at arab health 2025

Updates

2025.02.21

52

On the eve of the Lunar New Year, as families around the world celebrated the transition from the Year of the Dragon to the Year of the Snake, EverBridge Group's international team made its second appearance at Arab Health in Dubai, showcasing the latest products in peripheral intervention, neurointervention, and oncology. Marking its 50th anniversary in 2025, Arab Health is one of the most significant medical equipment exhibitions in the Middle East and globally. This year's event attracted approximately 3,800 exhibitors from over 180 countries and more than 60,000 professional visitors.

As a leading Chinese medical technology enterprise, EverBridge Group presented a range of innovative products at the exhibition, including industry-leading peripheral tapered balloons, peripheral treatment devices equipped with advanced radiofrequency ablation technology, and newly launched neuro catheters and peripheral guidewires. These products drew significant attention from distributors worldwide, with some samples running out due to high demand.

During the exhibition, EverBridge Group's international team welcomed numerous clients at their booth, including existing partners from the previous year and many new connections. Clients expressed high recognition of our balloons, catheters, and other products, showing strong interest in collaboration. This participation not only strengthened relationships with existing partners but also laid a solid foundation for exploring new markets and expanding our global business.


EverBridge Group remains committed to providing innovative, high-quality, and accessible medical technology solutions to patients worldwide. Through this exhibition, we further demonstrated our technological capabilities and product advantages while gaining a deeper understanding of the global market's urgent demand for high-quality medical products. Moving forward, we will continue to drive innovation, advance medical technology, and contribute to global healthcare.